# PubMatic, Inc.: financial statements, quarterly

PUBM · Nasdaq · CIK 1422930 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pubm.md) · [Financials](/companies/pubm/financials.md) · [Filings](/companies/pubm/filings.md) · [Insiders](/companies/pubm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pubm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [63.7](/filings/0001422930-24-000047.md) | [84.6 d](/filings/0001422930-26-000010.md) | [66.7](/filings/0001422930-25-000025.md) | [67.3](/filings/0001422930-25-000040.md) | [71.8](/filings/0001422930-25-000050.md) | [85.5 d](/filings/0001422930-26-000010.md) | [63.8](/filings/0001422930-26-000024.md) | [71.1](/filings/0001422930-26-000030.md) | [68.0](/filings/0001422930-25-000050.md) | [80.0 d](/filings/0001422930-26-000010.md) | [62.6](/filings/0001422930-26-000024.md) | [78.6](/filings/0001422930-26-000030.md) |
| Cost of revenue | $m | [26.1](/filings/0001422930-24-000047.md) | [24.2 d](/filings/0001422930-26-000010.md) | [25.4](/filings/0001422930-25-000025.md) | [25.2](/filings/0001422930-25-000040.md) | [25.5](/filings/0001422930-25-000050.md) | [24.9 d](/filings/0001422930-26-000010.md) | [25.6](/filings/0001422930-26-000024.md) | [26.6](/filings/0001422930-26-000030.md) | [25.4](/filings/0001422930-25-000050.md) | [25.5 d](/filings/0001422930-26-000010.md) | [26.1](/filings/0001422930-26-000024.md) | [25.9](/filings/0001422930-26-000030.md) |
| Gross profit | $m | [37.6](/filings/0001422930-24-000047.md) | [60.4 d](/filings/0001422930-26-000010.md) | [41.3](/filings/0001422930-25-000025.md) | [42.1](/filings/0001422930-25-000040.md) | [46.3](/filings/0001422930-25-000050.md) | [60.6 d](/filings/0001422930-26-000010.md) | [38.2](/filings/0001422930-26-000024.md) | [44.5](/filings/0001422930-26-000030.md) | [42.6](/filings/0001422930-25-000050.md) | [54.6 d](/filings/0001422930-26-000010.md) | [36.5](/filings/0001422930-26-000024.md) | [52.7](/filings/0001422930-26-000030.md) |
| Research and development | $m | [6.6](/filings/0001422930-24-000047.md) | [6.8 d](/filings/0001422930-26-000010.md) | [8.0](/filings/0001422930-25-000025.md) | [8.7](/filings/0001422930-25-000040.md) | [8.8](/filings/0001422930-25-000050.md) | [7.8 d](/filings/0001422930-26-000010.md) | [8.8](/filings/0001422930-26-000024.md) | [9.1](/filings/0001422930-26-000030.md) | [9.6](/filings/0001422930-25-000050.md) | [6.3 d](/filings/0001422930-26-000010.md) | [8.0](/filings/0001422930-26-000024.md) | [9.1](/filings/0001422930-26-000030.md) |
| Operating income | $m | [(0.6)](/filings/0001422930-24-000047.md) | [20.4 d](/filings/0001422930-26-000010.md) | [(5.5)](/filings/0001422930-25-000025.md) | [(4.0)](/filings/0001422930-25-000040.md) | [(1.4)](/filings/0001422930-25-000050.md) | [14.8 d](/filings/0001422930-26-000010.md) | [(11.9)](/filings/0001422930-26-000024.md) | [(5.5)](/filings/0001422930-26-000030.md) | [(8.4)](/filings/0001422930-25-000050.md) | [8.5 d](/filings/0001422930-26-000010.md) | [(15.3)](/filings/0001422930-26-000024.md) | [0.6](/filings/0001422930-26-000030.md) |
| Income tax | $m | [0.1](/filings/0001422930-24-000047.md) | [4.3 d](/filings/0001422930-26-000010.md) | [(0.2)](/filings/0001422930-25-000025.md) | [0.4](/filings/0001422930-25-000040.md) | [0.6](/filings/0001422930-25-000050.md) | [4.5 d](/filings/0001422930-26-000010.md) | [(1.8)](/filings/0001422930-26-000024.md) | [(0.9)](/filings/0001422930-26-000030.md) | [(1.7)](/filings/0001422930-25-000050.md) | [2.9 d](/filings/0001422930-26-000010.md) | [(2.6)](/filings/0001422930-26-000024.md) | [3.1](/filings/0001422930-26-000030.md) |
| Net income | $m | [1.8](/filings/0001422930-24-000047.md) | [18.7 d](/filings/0001422930-26-000010.md) | [(2.5)](/filings/0001422930-25-000050.md) | [2.0](/filings/0001422930-25-000050.md) | [(0.9)](/filings/0001422930-25-000050.md) | [13.9 d](/filings/0001422930-26-000010.md) | [(9.5)](/filings/0001422930-26-000030.md) | [(5.2)](/filings/0001422930-26-000030.md) | [(6.5)](/filings/0001422930-25-000050.md) | [6.7 d](/filings/0001422930-26-000010.md) | [(12.5)](/filings/0001422930-26-000030.md) | [(1.2)](/filings/0001422930-26-000030.md) |
| Diluted EPS | $ per share | [0.03](/filings/0001422930-24-000047.md) | [0.16](/filings/0001422930-24-000012.md) | [(0.05)](/filings/0001422930-25-000025.md) | [0.04](/filings/0001422930-25-000040.md) | [(0.02)](/filings/0001422930-25-000050.md) | not reported | [(0.20)](/filings/0001422930-26-000024.md) | [(0.11)](/filings/0001422930-26-000030.md) | [(0.14)](/filings/0001422930-25-000050.md) | not reported | [(0.27)](/filings/0001422930-26-000024.md) | [(0.03)](/filings/0001422930-26-000030.md) |
| Basic EPS | $ per share | [0.03](/filings/0001422930-24-000047.md) | not reported | [(0.05)](/filings/0001422930-25-000025.md) | [0.04](/filings/0001422930-25-000040.md) | [(0.02)](/filings/0001422930-25-000050.md) | not reported | [(0.20)](/filings/0001422930-26-000024.md) | [(0.11)](/filings/0001422930-26-000030.md) | [(0.14)](/filings/0001422930-25-000050.md) | not reported | [(0.27)](/filings/0001422930-26-000024.md) | [(0.03)](/filings/0001422930-26-000030.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [97.7](/filings/0001422930-23-000058.md) | [78.5](/filings/0001422930-25-000012.md) | [80.2](/filings/0001422930-24-000027.md) | [73.5](/filings/0001422930-24-000041.md) | [78.9](/filings/0001422930-24-000047.md) | [100](/filings/0001422930-26-000010.md) | [102](/filings/0001422930-25-000025.md) | [90.5](/filings/0001422930-25-000040.md) | [137](/filings/0001422930-25-000050.md) | [146](/filings/0001422930-26-000030.md) | [145](/filings/0001422930-26-000024.md) | [120](/filings/0001422930-26-000030.md) |
| Current assets | $m | [474](/filings/0001422930-23-000058.md) | [562](/filings/0001422930-25-000012.md) | [489](/filings/0001422930-24-000027.md) | [532](/filings/0001422930-24-000041.md) | [530](/filings/0001422930-24-000047.md) | [576](/filings/0001422930-26-000010.md) | [505](/filings/0001422930-25-000025.md) | [513](/filings/0001422930-25-000040.md) | [520](/filings/0001422930-25-000050.md) | [523](/filings/0001422930-26-000030.md) | [504](/filings/0001422930-26-000024.md) | [538](/filings/0001422930-26-000030.md) |
| Total assets | $m | [613](/filings/0001422930-23-000058.md) | [695](/filings/0001422930-25-000012.md) | [626](/filings/0001422930-24-000027.md) | [673](/filings/0001422930-24-000041.md) | [689](/filings/0001422930-24-000047.md) | [740](/filings/0001422930-26-000010.md) | [669](/filings/0001422930-25-000025.md) | [675](/filings/0001422930-25-000040.md) | [676](/filings/0001422930-25-000050.md) | [680](/filings/0001422930-26-000030.md) | [659](/filings/0001422930-26-000024.md) | [700](/filings/0001422930-26-000030.md) |
| Current liabilities | $m | [304](/filings/0001422930-23-000058.md) | [380](/filings/0001422930-25-000012.md) | [316](/filings/0001422930-24-000027.md) | [370](/filings/0001422930-24-000041.md) | [393](/filings/0001422930-24-000047.md) | [419](/filings/0001422930-26-000010.md) | [350](/filings/0001422930-25-000025.md) | [389](/filings/0001422930-25-000040.md) | [388](/filings/0001422930-25-000050.md) | [376](/filings/0001422930-26-000030.md) | [369](/filings/0001422930-26-000024.md) | [422](/filings/0001422930-26-000030.md) |
| Total liabilities | $m | [324](/filings/0001422930-23-000058.md) | [399](/filings/0001422930-25-000012.md) | [337](/filings/0001422930-24-000027.md) | [390](/filings/0001422930-24-000041.md) | [426](/filings/0001422930-24-000047.md) | [462](/filings/0001422930-26-000010.md) | [393](/filings/0001422930-25-000025.md) | [432](/filings/0001422930-25-000040.md) | [431](/filings/0001422930-25-000050.md) | [418](/filings/0001422930-26-000030.md) | [408](/filings/0001422930-26-000024.md) | [461](/filings/0001422930-26-000030.md) |
| Shareholders' equity | $m | [289](/filings/0001422930-24-000047.md) | [296](/filings/0001422930-26-000010.md) | [289](/filings/0001422930-25-000050.md) | [283](/filings/0001422930-25-000050.md) | [263](/filings/0001422930-25-000050.md) | [277](/filings/0001422930-26-000030.md) | [276](/filings/0001422930-26-000030.md) | [243](/filings/0001422930-26-000030.md) | [245](/filings/0001422930-25-000050.md) | [263](/filings/0001422930-26-000030.md) | [251](/filings/0001422930-26-000030.md) | [239](/filings/0001422930-26-000030.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [23.8 d](/filings/0001422930-24-000047.md) | [28.7 d](/filings/0001422930-26-000010.md) | [24.3](/filings/0001422930-25-000025.md) | [11.9 d](/filings/0001422930-25-000040.md) | [19.1 d](/filings/0001422930-25-000050.md) | [18.0 d](/filings/0001422930-26-000010.md) | [15.6](/filings/0001422930-26-000024.md) | [14.9 d](/filings/0001422930-26-000030.md) | [32.4 d](/filings/0001422930-25-000050.md) | [18.2 d](/filings/0001422930-26-000010.md) | [17.3](/filings/0001422930-26-000024.md) | [20.2 d](/filings/0001422930-26-000030.md) |
| Capital expenditure | $m | [2.9 d](/filings/0001422930-24-000047.md) | [5.2 d](/filings/0001422930-26-000010.md) | [0.8](/filings/0001422930-25-000025.md) | [0.7 d](/filings/0001422930-25-000040.md) | [11.7 d](/filings/0001422930-25-000050.md) | [4.3 d](/filings/0001422930-26-000010.md) | [1.4](/filings/0001422930-26-000024.md) | [1.3 d](/filings/0001422930-26-000030.md) | [4.7 d](/filings/0001422930-25-000050.md) | [6.9 d](/filings/0001422930-26-000010.md) | [0.0](/filings/0001422930-26-000024.md) | [3.0 d](/filings/0001422930-26-000030.md) |
| Share repurchases | $m | [18.0 d](/filings/0001422930-24-000047.md) | [17.8 d](/filings/0001422930-26-000010.md) | [17.5](/filings/0001422930-25-000025.md) | [18.4 d](/filings/0001422930-25-000040.md) | [29.5 d](/filings/0001422930-25-000050.md) | [9.9 d](/filings/0001422930-26-000010.md) | [5.0](/filings/0001422930-26-000024.md) | [38.6 d](/filings/0001422930-26-000030.md) | [4.0 d](/filings/0001422930-25-000050.md) | [(1.2) d](/filings/0001422930-26-000010.md) | [8.5](/filings/0001422930-26-000024.md) | [22.0 d](/filings/0001422930-26-000030.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [52.7](/filings/0001422930-24-000027.md) | [52.0](/filings/0001422930-24-000041.md) | [56.0](/filings/0001422930-24-000047.md) | [56.0](/filings/0001422930-24-000012.md) | [50.0](/filings/0001422930-25-000025.md) | [55.6](/filings/0001422930-25-000040.md) | [49.1](/filings/0001422930-25-000050.md) | [48.3](/filings/0001422930-26-000024.md) | [47.2](/filings/0001422930-26-000030.md) | [45.9](/filings/0001422930-25-000050.md) | [47.1](/filings/0001422930-26-000024.md) | [46.1](/filings/0001422930-26-000030.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.